Quick Takeaways
- Stephen W. Webster has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $64,731.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Stephen W. Webster and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| GRTS | Gritstone bio, Inc. | Director | $47,560 | 04 Apr 2025 | ||
| NBRV | Nabriva Therapeutics plc | Director | $17,171 | 02 Aug 2022 | ||
| CGEM | Cullinan Therapeutics, Inc. | Director | 12 Jun 2025 | |||
| NXTC | NextCure, Inc. | Director | 20 Jun 2025 | |||
| TCRR | TCR2 THERAPEUTICS INC. | Director | 01 Jun 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|